Table 1 Clinicopathological characteristics of the 336 cervical cancer patients
| Â | Frequency | % |
|---|---|---|
Age | ||
 Mean ± SD | 48.9 ± 11.2 |  |
FIGO stage | ||
 IB1/IIA | 291 | 86.6 |
 IB2/IIB | 45 | 13.4 |
Cell type | ||
 SCC | 256 | 76.2 |
 AD/ASC | 80 | 23.8 |
Tumor size | ||
 ≤4 cm | 256 | 76.2 |
 >4 cm | 80 | 23.8 |
SCC Ag level (ng/ml) | ||
 Median (range) | 1.2 (0.1–65.1) |  |
LVSI | ||
 Negative | 202 | 60.1 |
 Positive | 134 | 39.9 |
Depth of invasion | ||
 <50 % | 108 | 32.1 |
 >50 % | 228 | 67.9 |
LN metastasis | ||
 Negative | 256 | 76.2 |
 Positive | 80 | 23.8 |
PM involvement | ||
 Negative | 305 | 90.8 |
 Positive | 31 | 9.2 |
Resection margin | ||
 Negative | 323 | 96.1 |
 Positive | 13 | 3.9 |
Primary treatment | ||
 OP only | 171 | 50.9 |
 OP + RT | 70 | 20.8 |
 OP + CCRT | 90 | 26.8 |
 Neoadjuvant | 5 | 1.5 |